Bunzl (BNZL.L) - Company Research
Last Updated: 27 April 2026
Bunzl (LSE: BNZL) is the FTSE 100 specialist distributor of "not-for-resale" consumables – foodservice packaging, safety equipment, hygiene & cleaning, healthcare and retail bags – and is best understood as a programmatic, low-margin compounder. The 2 March 2026 FY25 results showed group revenue of £11.85 bn (+3.0% constant-FX) and adjusted operating profit of £910.3 m (margin 7.7%), one year on from the disruptive April 2025 trading update which paused the £200 m buyback (later resumed and completed in October 2025) and triggered a one-day share-price drop of ~24%. The Q1 2026 trading update on 23–24 April reported underlying revenue +2.0% with North America back in line with the group; AGM passed all resolutions on 22 April. This report covers the FY25 numbers, the geographic and customer-market mix, the pipeline of bolt-on M&A (1,300+ targets identified) and the principal risks: tariff exposure, FX (~53% of revenue is North America), and execution on the own-brand programme that disappointed in 2024–25.
1. Company Snapshot
| Company | Bunzl plc |
| Ticker | LSE: BNZL (ADR: BZLFY) |
| Sector / Industry | FTSE 100 Industrials – Distribution & Outsourcing Services |
| HQ | 5 Broadgate, London EC2M 2QS |
| CEO | Frank van Zanten (since April 2016) |
| CFO | Richard Howes (since January 2020) |
| North America CEO | James McCool |
| Chair | Peter Ventress |
| Founded | 1854 (Pozsony / Bratislava); UK incorporation 1940; Bunzl name 1972 |
| Employees | ~26,978 (end-2024; FY25 not yet disclosed) |
| Fiscal year end | 31 December |
| Share price (24 Apr 2026) | 2,447.0p (+0.91%) |
| 52-week range | 1,982 – 2,608p |
| Market cap | ~£7.86 bn |
| FY2025 revenue | £11,845.4 m (+3.0% constant-FX; +0.6% reported) |
| FY2025 adjusted operating profit | £910.3 m (margin 7.7%) |
| FY2025 free cash flow | £579 m (cash conversion 95%) |
| Total dividend FY2025 | 74.1p (53.9p final + 20.2p interim) |
| Dividend yield | ~3.03% |
| Net debt / EBITDA | 2.0× (year-end 2025) |
| Next results | H1 2026 – expected late August 2026 |
2. Bull Case vs Bear Case
| Bull Case | Bear Case |
|---|---|
| FY25 revenue +3.0% constant-FX to £11.85 bn; cash conversion 95%; FCF £579 m; net debt / EBITDA 2.0× remains supportive of M&A and capital returns. | FY25 adjusted operating profit fell to £910.3 m (-4.3%); margin 7.7% vs 8.3% FY24; FCF -8.7%; the legacy "Bunzl model" of margin expansion has stalled. |
| Acquisition flywheel intact – 1,300+ targets identified; 8 deals in 2025 (£132 m); 13 deals in 2024 (£883 m); £200 m buyback completed in October 2025; capital allocation guide ~£700 m p.a. through 2027. | April 2025 guidance cut and buyback pause was a -24% one-day share move; cited "execution issues" in North America (own-brand ramp, deflation) plus tariff uncertainty. The buyback resumed but the credibility scar remains. |
| Q1 2026 underlying revenue +2.0% (volume + tariff price); North America growth in line with group, recovering from 2024–25 weakness; pipeline described as active with improved acquisition outlook. | FY25 group margin compressed in North America to 7.0% on own-brand mis-execution; deflation was a real headwind to a business that depends on mild inflation pass-through. |
| Diversified, fragmented end-markets: foodservice 31.2%, grocery 24.2%, safety 14.9%, cleaning & hygiene 10.5%, retail 7.8%, healthcare 7.0%; ~150,000 customers; no party with >10% market share, including Bunzl itself. | ~53% of revenue from North America – FX swings flow directly to reported results (FY25 group +3.0% cFX vs +0.6% reported = ~240 bps drag). Tariff price-throughs in Q1 2026 helped underlying revenue but raise upstream cost and elasticity questions. |
| 74.1p total FY25 dividend marks ~30 consecutive years of increases – one of the longest UK quoted records; final 53.9p ex-div 21 May 2026, paid 2 July 2026. | Margin trajectory from here depends heavily on improving North American own-brand mix back to ~30%+ penetration and successful re-acceleration of bolt-on M&A; no major deals announced YTD 2026 in retrievable sources. |
3. What Does This Company Actually Do?
Bunzl is a specialist international distributor of "not-for-resale" consumables that other businesses use up daily but don’t sell on. Categories include foodservice packaging (cups, lids, containers, takeaway boxes), safety equipment (PPE, gloves, footwear), cleaning and hygiene supplies, healthcare disposables, retail bags and shelf-edge furniture. The customer base – ~150,000 across foodservice operators, grocers, safety end-users, cleaning contractors, healthcare providers and retailers – is highly diversified, with no individual customer material to the group.
Operations span North America, Continental Europe, the UK & Ireland and Rest of World (Latin America, Australasia, Asia, Middle East). Digital orders represent ~76% of total orders in 2025; own-brand penetration in North America is ~30%.
FY2025 customer-market mix (% of £11,845.4 m):
| Customer market | % of revenue | Approx. revenue (£m) |
|---|---|---|
| Foodservice | 31.2% | ~3,696 |
| Grocery | 24.2% | ~2,866 |
| Safety | 14.9% | ~1,765 |
| Cleaning & Hygiene | 10.5% | ~1,244 |
| Retail | 7.8% | ~924 |
| Healthcare | 7.0% | ~829 |
| Other | 4.4% | ~521 |
Geographic split (FY2025):
| Region | Revenue (£m) | Constant-FX growth | Op profit (£m) | Op margin |
|---|---|---|---|---|
| North America | 6,276.7 | -1.2% | 440.5 | 7.0% |
| Continental Europe | 2,442.0 | +2.5% | 204.7 | 8.4% |
| UK & Ireland | 1,883.6 | +15.9% | 153.1 | 8.1% |
| Rest of World | 1,243.1 | +9.1% | 145.3 | 11.7% |
| Group | 11,845.4 | +3.0% | 910.3 | 7.7% |
4. The Business Model
Low-margin, high-volume, high-cash aggregator. Group operating margin has oscillated in the 7–8% range over the past five years; cash conversion was 95% in FY25 and has averaged ~95–102% over the cycle. The defining feature is the "Bunzl model" of bolt-on M&A: the company has completed over 200 acquisitions in 20 years and identifies 1,300+ targets in its current pipeline (FY25 release). Average deal size is small – the 2025 cohort of 8 deals averaged ~£16 m of committed spend each.
Capital allocation framework (re-stated 2024): ~£700 m p.a. for value-accretive acquisitions and/or returns of capital across the three years to 31 December 2027. The £200 m buyback announced in late 2024 was paused in April 2025 (after only ~£115 m repurchased) and resumed in H2 2025, completing in October 2025.
Operating economics:
- Gross margin disclosure varies by region; group adjusted operating margin 7.7% (FY25), 8.3% (FY24), ~8.0% (FY23), ~6.9% (FY22), ~7.3% (FY21).
- North America FY25 op margin compressed to 7.0% on own-brand mis-execution and deflation.
- UK & Ireland and Rest of World grew double-digits in cFX terms in FY25.
- Digital orders ~76% of order volume in 2025 (ainvest summary).
5. Financial Health
Five-year financials (FY2021–FY2025):
| Metric | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue (£m) | 10,285.1 | 12,039.5 | 11,797 | 11,776.4 | 11,845.4 |
| Adj op profit (£m) | 752.8 | ~830 | ~944.2 | 976.1 | 910.3 |
| Adj op margin | ~7.3% | 6.9% | ~8.0% | 8.3% | 7.7% |
| Statutory op profit (£m) | 644.7 | 757.5 | 810.6 | 799.3 | 735.3 |
| Net income (£m) | 442.8 | 474.4 | 526.2 | 500.4 | 459.2 |
| Adj EPS (p) | n/a | n/a | n/a | 194.3 | 179.3 |
| Statutory EPS (p) | 132 | 141 | 156 | 149.6 | 141.5 |
| Total DPS (p) | 57.0 | 62.7 | 68.3 | 73.9 | 74.1 |
| FCF (£m) | strong (102%) | n/a | n/a | n/a | 579 (-8.7%) |
| Net debt / EBITDA | 1.6× | n/a | 1.1× | n/a | 2.0× |
Recent half-year periods:
| Period | Revenue (£m) | Adj op profit (£m) | Adj op margin |
|---|---|---|---|
| H1 2024 | 5,711.5 | 455.5 | 8.0% |
| H2 2024 (derived) | ~6,065 | ~520 | 8.6% |
| H1 2025 | 5,759.6 | 404.5 | 7.0% |
| H2 2025 (derived) | ~6,086 | ~505.8 | 8.3% |
| Q1 2026 (trading update) | cFX +1.5%; underlying +2.0% | "consistent with expectations" | n/d |
Capital structure (year-end 2025): Net debt / EBITDA 2.0× (vs ~1.1× FY23 and 1.6× FY21); the £200 m buyback completed in October 2025; FY25 ended with leverage in the upper half of the company’s comfort range. The 2024 reset of the capital framework guides ~£700 m p.a. for M&A and/or returns through to end-2027.
6. Valuation & Market Data
| Share price (24 Apr 2026) | 2,447.0p |
| Market cap | ~£7.86 bn |
| Enterprise value (approx) | ~£9.77 bn |
| 52-week range | 1,982 – 2,608p |
| Trailing P/E | ~17.4× (Investing.com); ~12.6–15.6× (alt sources) |
| EV / EBITDA | ~12.8× (March 2026) |
| Price / Sales | ~0.66× |
| FCF yield | ~7.4% (on £579 m FY25 FCF / £7.86 bn cap) |
| Net debt | ~£1.91 bn (2.0× FY25 EBITDA £952.5 m) |
| Dividend yield | ~3.03% |
| FY25 total dividend | 74.1p (final 53.9p + interim 20.2p) |
| Final dividend ex-div / payment | 21 May 2026 / 2 July 2026 |
For context: the April 2025 trading update (16 April 2025) cut full-year guidance and paused the £200 m buyback (~£115 m executed). Shares fell 23.9% on the day. The buyback resumed in H2 2025 and completed in October 2025.
7. What Are They Building / What’s Coming?
- Acquisition pipeline – 1,300+ targets identified per the FY25 release; capital allocation guide ~£700 m p.a. for M&A and/or buybacks through 2027.
- Recent deals – FY25 saw 8 deals (£132 m committed), described as a slow year. Notable transactions: Quindesur (Spanish foodservice distributor, Aug 2025), Guantes Internacionales / Gisa (Mexican PPE, Aug 2025), Damito s.r.o. (Slovakia, Oct 2025; ~€14 m revenue / ~£12 m). FY24 was a record acquisition year: 13 deals, £883 m committed spend.
- 2026 outlook – per Q1 2026 trading update, the pipeline is "active" with an "improved outlook" for deal-making relative to 2025. No major 2026 deal announcements confirmed in retrievable sources as of 27 April 2026.
- Sustainability targets – Net zero scope 1+2 by 2030 (interim: 27.5% absolute reduction vs 2019; 50% more carbon-efficient by 2030); net zero scope 1+2+3 by 2050; 79% of suppliers (by emissions) to have SBTi-validated targets by 2027; phase-out of "problematic" single-use plastics; SBTi-approved targets.
- Digital transformation – ~76% of orders digital; North America own-brand penetration ~30% (an opportunity to mid-30s%).
8. Competitive Landscape
Bunzl operates in a highly fragmented set of end-markets. Management characterises the addressed markets as having no party with greater than ~10% share, including Bunzl itself. The closest direct competitors:
| Competitor | Region / category | Notes |
|---|---|---|
| Imperial Dade | North America non-food disposables & packaging | Private; rapid roll-up; serves 75,000+ customers across US/Canada (similar acquisition-led model) |
| Veritiv | North America packaging & janitorial | Private since CD&R take-private (2023) |
| Brady Industries | North America cleaning & janitorial | Regional / mid-market |
| HD Supply (Home Depot) | Multifamily / hospitality | Subsidiary of Home Depot |
| Sysco / US Foods / Performance Food Group | North America foodservice (food) | Adjacent – distribute the food; Bunzl distributes the disposables/packaging around it |
| McKesson Medical-Surgical, Cardinal Health, Henry Schein, Owens & Minor | Healthcare consumables | Larger players in healthcare distribution; Bunzl's healthcare segment is ~7% of revenue |
| Cintas, Ecolab, Grainger, Uline | Cleaning / hygiene chemicals or industrial supply | Adjacent / different go-to-market |
Hard market-share percentages by sub-segment are not reliably published – the cohort is too fragmented. Bunzl’s own segment disclosure characterises the addressed market as >90% non-Bunzl. Accordingly, this article does not include a competitor share chart.
9. Leadership and Ownership
| Chief Executive Officer | Frank van Zanten (since April 2016) |
| Chief Financial Officer | Richard Howes (since January 2020; ex-Inchcape, Coats, Bakkavor) |
| CEO, North America | James McCool |
| Chair | Peter Ventress |
Top institutional holders (most recent figures available, 2022–2024):
| Holder | ~% of shares |
|---|---|
| Mawer Investment Management | ~9.3% |
| BlackRock Inc | ~7.2% |
| Vanguard Group | ~4.3% |
| Material additional holders (Schroder Investment Management, FIL/Fidelity, Invesco, Capital International) | Various |
| Aggregate institutional ownership | ~87% |
Recent insider activity (last 12 months):
| Date | Insider | Activity |
|---|---|---|
| 13 Apr 2026 | PDMR (RNS 2590A) | Director / PDMR shareholding notification |
| 9 Apr 2026 | Frank van Zanten (CEO) | Increased stake after exercising share awards |
| 2 Apr 2026 | James McCool (NA CEO) | 91-share Employee Stock Purchase Plan acquisition at $26.0614 |
| 7 Jan 2026 | PDMR | Director / PDMR shareholding RNS |
10. Risks and Challenges
- M&A integration & own-brand execution – the April 2025 guidance cut and buyback pause were driven by North America own-brand mis-execution and deflation; recovery was visible in Q1 2026 but the credibility scar remains.
- FX exposure – ~53% of revenue and the majority of profit from North America; FY25 group revenue +3.0% constant-FX vs +0.6% reported = ~240 bps drag; USD strength/weakness flows directly to reported numbers.
- Tariffs – Q1 2025 statement cited "significant uncertainties relating to tariffs and their impact on inflation and economic growth"; Q1 2026 statement notes "tariff-related price increases" supporting underlying revenue +2.0% – raises upstream cost and elasticity questions.
- Inflation pass-through – Bunzl historically benefits from mild inflation (volume + price) and is hurt by deflation (the 2024 North America experience).
- Customer concentration – low – typically a strength; ~150,000 customers across all segments.
- Labour cost inflation – multi-warehouse, multi-truck operating model with wage exposure across UK / US / Europe.
- Plastics regulation – single-use plastics legislation in EU and UK is a margin risk on the foodservice disposables category but also an own-brand opportunity (sustainable substitutes).
- Deal-flow dependency – the "Bunzl model" requires a steady cadence of bolt-on M&A; 2025 was a slow year (£132 m vs £883 m FY24) and 2026 has not yet seen major announcements.
11. Recent Developments
Last week:
- 24 Apr 2026 – Shares closed at 2,447.0p (+0.91%) with day range 2,414–2,459p on volume 1.52 m (Investing.com / LSE).
- 23–24 Apr 2026 – Q1 2026 trading update: group revenue cFX +1.5% (-0.4% reported); underlying +2.0% (volume + tariff price); acquisitions +0.6%; trading-day drag -1.1%; North America underlying growth slightly ahead of group; adjusted operating profit "consistent with expectations"; 2026 guidance reiterated (moderate revenue growth, op margin slightly down YoY); pipeline active with improved acquisition outlook.
- 22 Apr 2026 – 2026 AGM – all resolutions passed including the FY25 final dividend of 53.9p (TipRanks).
- 13 Apr 2026 – PDMR Shareholding RNS 2590A (advfn).
Last six months:
- 2 Mar 2026 – FY2025 results: revenue £11,845.4 m (+3.0% cFX, +0.6% reported); adj op profit £910.3 m (-4.3%); margin 7.7%; FCF £579 m (-8.7%); cash conversion 95%; total DPS 74.1p (+0.3%); 8 deals / £132 m committed spend; year-end leverage 2.0×.
- 17 Mar 2026 – Annual Report 2025 published; 2026 AGM date announced.
- October 2025 – £200 m buyback (paused April 2025) completed.
- December 2025 pre-close – FY25 revenue guided +2–3% cFX; op margin ~7.6%; year-end leverage ~2.0×.
- 16 Apr 2025 – Q1 2025 trading update cut full-year guidance and paused the £200 m buyback (~£115 m executed); shares fell -23.9% on the day citing North America "execution issues" and tariff uncertainty.
12. Key Dates Coming Up
| Date | Event |
|---|---|
| 21 May 2026 | Final dividend ex-div (53.9p) |
| 22 May 2026 | Final dividend record date |
| 2 July 2026 | Final dividend payment |
| Late August 2026 (typical) | H1 2026 results |
| Mid-October 2026 (typical) | Q3 2026 trading update |
| Mid-December 2026 (typical) | Pre-close 2026 statement |
| April 2027 | 2027 AGM (2026 AGM was 22 April 2026) |
Explore further on ChartsView:
Disclaimer: This research note is prepared for educational and informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. ChartsView and its authors are not registered investment advisers. All financial figures are sourced from Bunzl plc press releases (FY2025 results 2 March 2026, Q1 2026 trading update 23–24 April 2026), Annual Report 2025 (17 March 2026) and reputable financial media as of 27 April 2026 and may be subject to revision. Distribution-sector investing carries the additional risks that volume / price dynamics, tariff regimes, FX moves (~53% North America revenue) and bolt-on M&A integration outcomes can move share prices materially in either direction.
Loading research report…
13. Thesis Verdict
The central thesis. Bunzl is a specialist international distributor of "not-for-resale" consumables — foodservice packaging, safety equipment, cleaning and hygiene supplies, healthcare disposables and retail goods — serving roughly 150,000 customers across diversified end-markets, with no single customer or category dominant. The model is low-margin, high-volume and high-cash, with FY25 cash conversion of 95% and free cash flow of £579m. The structural driver is a bolt-on M&A flywheel: over 200 deals in 20 years, a stated pipeline of 1,300+ targets, and a capital allocation framework guiding ~£700m per annum through 2027 for acquisitions and/or capital returns. The nearest catalyst is re-acceleration of deal-flow in 2026, with the Q1 2026 update describing the pipeline as active with an improved outlook.
What would confirm or break it. Confirmation would come from a step-up in announced bolt-ons towards the £700m annual envelope, North American margin recovery from the FY25 trough of 7.0%, and stable underlying volume growth above the Q1 2026 +2.0% pace. Materialisation of further own-brand mis-execution, prolonged deflation, adverse FX (FY25 saw ~240bps reported drag), tariff-driven elasticity issues, or a continued slow deal cadence after 2025's £132m would weaken the structural case.
Watchpoints
- ConfirmsSubsequent earnings and filings reinforcing the figures presented in this report.
- ConfirmsSubsequent earnings and filings reinforcing the figures presented in this report.
- InvalidatesAny disclosure that directly contradicts a material claim in the bull case.
Diagnostic grid
Generated by ChartsView research tooling. Thesis strength measures how well the evidence in this report supports the company's stated thesis — it is NOT a buy/sell rating or price target. ChartsView is not authorised by the FCA to provide regulated investment advice. Generated 27 Apr 2026.